Page last updated: 2024-10-26

3,4-dihydroxybenzohydroxamic acid and Chronic Disease

3,4-dihydroxybenzohydroxamic acid has been researched along with Chronic Disease in 1 studies

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaul, DK1
Kollander, R1
Mahaseth, H1
Liu, XD1
Solovey, A1
Belcher, J1
Kelm, RJ1
Vercellotti, GM1
Hebbel, RP1

Other Studies

1 other study available for 3,4-dihydroxybenzohydroxamic acid and Chronic Disease

ArticleYear
Robust vascular protective effect of hydroxamic acid derivatives in a sickle mouse model of inflammation.
    Microcirculation (New York, N.Y. : 1994), 2006, Volume: 13, Issue:6

    Topics: Anemia, Sickle Cell; Animals; Benzamidines; Blood Coagulation; Cell Communication; Chronic Disease;

2006